Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1921 2
1931 1
1933 4
1937 2
1938 3
1939 2
1943 1
1946 3
1947 4
1948 1
1949 4
1950 2
1951 2
1952 1
1953 3
1954 3
1955 5
1956 9
1957 4
1958 5
1959 2
1960 6
1961 4
1962 6
1963 9
1964 6
1965 7
1966 8
1967 8
1968 5
1969 8
1970 12
1971 18
1972 29
1973 26
1974 36
1975 57
1976 64
1977 55
1978 51
1979 57
1980 49
1981 64
1982 58
1983 58
1984 62
1985 74
1986 69
1987 94
1988 99
1989 116
1990 115
1991 143
1992 130
1993 111
1994 148
1995 159
1996 188
1997 172
1998 180
1999 142
2000 181
2001 230
2002 185
2003 196
2004 202
2005 228
2006 226
2007 243
2008 284
2009 296
2010 258
2011 255
2012 284
2013 309
2014 327
2015 341
2016 371
2017 355
2018 341
2019 372
2020 473
2021 452
2022 448
2023 443
2024 185

Text availability

Article attribute

Article type

Publication date

Search Results

9,308 results

Results by year

Filters applied: . Clear all
Page 1
Acute myeloid leukaemia.
DiNardo CD, Erba HP, Freeman SD, Wei AH. DiNardo CD, et al. Lancet. 2023 Jun 17;401(10393):2073-2086. doi: 10.1016/S0140-6736(23)00108-3. Epub 2023 Apr 15. Lancet. 2023. PMID: 37068505 Review.
Progress in acute myeloid leukaemia treatment is occurring at an unprecedented pace. ...The classification of acute myeloid leukaemia has recently been updated by WHO and the International Consensus Classification (ICC). ...
Progress in acute myeloid leukaemia treatment is occurring at an unprecedented pace. ...The classification of acute myeloid …
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE. Short NJ, et al. Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2. Lancet. 2018. PMID: 30078459 Free PMC article. Review.
For several decades, few substantial therapeutic advances have been made for patients with acute myeloid leukaemia. However, since 2017 unprecedented growth has been seen in the number of drugs available for the treatment of acute myeloid leukaemia, wi …
For several decades, few substantial therapeutic advances have been made for patients with acute myeloid leukaemia. However, s …
Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia.
Bain BJ, Béné MC. Bain BJ, et al. Acta Haematol. 2019;141(4):232-244. doi: 10.1159/000496097. Epub 2019 Apr 9. Acta Haematol. 2019. PMID: 30965338 Free article. Review.
Diagnosis and classification of acute myeloid leukaemia (AML) require cytogenetic and molecular genetic investigation. ...
Diagnosis and classification of acute myeloid leukaemia (AML) require cytogenetic and molecular genetic investigation. ...
Chronic myeloid leukaemia.
Apperley JF. Apperley JF. Lancet. 2015 Apr 11;385(9976):1447-59. doi: 10.1016/S0140-6736(13)62120-0. Epub 2014 Dec 5. Lancet. 2015. PMID: 25484026 Review.
In less than 10 years, the prognosis of chronic myeloid leukaemia has changed from that of a fatal disease to a disorder amenable simply to lifelong oral medication and compatible with a normal lifespan. ...Chronic myeloid leukaemia continues to instru …
In less than 10 years, the prognosis of chronic myeloid leukaemia has changed from that of a fatal disease to a disorder amena …
Asciminib for chronic myeloid leukaemia.
[No authors listed] [No authors listed] Aust Prescr. 2022 Dec;45(6):211-212. doi: 10.18773/austprescr.2022.070. Epub 2022 Oct 12. Aust Prescr. 2022. PMID: 36479334 Free PMC article. Review. No abstract available.
The power and potential of integrated diagnostics in acute myeloid leukaemia.
Haferlach T, Schmidts I. Haferlach T, et al. Br J Haematol. 2020 Jan;188(1):36-48. doi: 10.1111/bjh.16360. Epub 2019 Dec 6. Br J Haematol. 2020. PMID: 31808952 Free PMC article. Review.
The field of acute myeloid leukaemia (AML) diagnostics, initially based solely on morphological assessment, has integrated more and more disciplines. ...
The field of acute myeloid leukaemia (AML) diagnostics, initially based solely on morphological assessment, has integrated mor …
Acute myeloid leukaemia genomics.
Medinger M, Passweg JR. Medinger M, et al. Br J Haematol. 2017 Nov;179(4):530-542. doi: 10.1111/bjh.14823. Epub 2017 Jun 27. Br J Haematol. 2017. PMID: 28653397 Free article. Review.
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous disease. ...
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous disease. ...
Epigenetics of paediatric acute myeloid leukaemia.
Jones L, McCarthy P, Bond J. Jones L, et al. Br J Haematol. 2020 Jan;188(1):63-76. doi: 10.1111/bjh.16361. Epub 2019 Dec 5. Br J Haematol. 2020. PMID: 31804725 Free article. Review.
Comprehensive cataloguing of the acute myeloid leukaemia (AML) genome has revealed a high frequency of mutations and deletions in epigenetic factors that are frequently linked to treatment resistance and poor patient outcome. ...
Comprehensive cataloguing of the acute myeloid leukaemia (AML) genome has revealed a high frequency of mutations and deletions …
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database.
Morice PM, Leary A, Dolladille C, Chrétien B, Poulain L, González-Martín A, Moore K, O'Reilly EM, Ray-Coquard I, Alexandre J. Morice PM, et al. Lancet Haematol. 2021 Feb;8(2):e122-e134. doi: 10.1016/S2352-3026(20)30360-4. Epub 2020 Dec 18. Lancet Haematol. 2021. PMID: 33347814
However, some concerns have emerged regarding rare and delayed adverse events including cases of myelodysplastic syndrome and acute myeloid leukaemia, for which data are scarce. The aim of this study was to estimate the risk of myelodysplastic syndrome and acute …
However, some concerns have emerged regarding rare and delayed adverse events including cases of myelodysplastic syndrome and acute myelo …
Acute myeloid leukaemia and the immune system: implications for immunotherapy.
Barrett AJ. Barrett AJ. Br J Haematol. 2020 Jan;188(1):147-158. doi: 10.1111/bjh.16310. Epub 2019 Nov 29. Br J Haematol. 2020. PMID: 31782805 Free article. Review.
The recognition of the curative potential of the graft-versus-leukaemia effect for patients with acute myeloid leukaemia (AML) undergoing stem cell transplantation, and the emergence of immunotherapy as a powerful weapon to treat cancer, has spurred the exploration …
The recognition of the curative potential of the graft-versus-leukaemia effect for patients with acute myeloid leukaemia (AML) …
9,308 results